Figure 2.
Furin nanobodies. Furin nanobodies consisting of the variable region of an antibody specific for the P-domain of furin, binds this regulatory region, inhibiting the binding of furin to physiological substrates. Note the change in shape in the catalytic site upon Nb14 binding to the P-site.